Barinthus Biotherapeutics plc (BRNS)
NASDAQ·Healthcare·Biotechnology
$0.62
-2.13%
Mkt Cap $22.95M
Analyst Ratings
No recent rating data.
Price Target (3 analysts)
$3.00
Range $3.00 – $3.00
Implied Upside
+386.5%
Consensus $3.00 vs current $0.62
NASDAQ·Healthcare·Biotechnology
$0.62
-2.13%
Mkt Cap $22.95M
No recent rating data.
Price Target (3 analysts)
$3.00
Range $3.00 – $3.00
+386.5%
Consensus $3.00 vs current $0.62